Highest-materiality recent filing
Inotiv emerges from Chapter 11; old equity canceled, new $180M exit facility, warrants issued
All 35,177,867 common shares canceled; existing equity holders received no distribution.
Inotiv bankruptcy court confirms Chapter 11 plan; existing equity to be canceled
Bankruptcy court confirmed plan on July 14, 2026; company expects to emerge shortly as private company.
Inotiv enters $65.5M DIP financing, Nasdaq to delist shares June 11; expects total equity loss
DIP facility: $25M new money term loans + $40.5M roll-up of prepetition bridge loans; interest at Adjusted Term SOFR + 11.5%.
Inotiv files prepackaged Chapter 11; to cut debt by $326M, cancel existing equity
Debt reduction of approx. $326M through conversion of funded debt into reorganized company equity.
Company failed to make $2.139M interest payment on 3.25% Convertible Senior Notes due 2027 on April 15, 2026.
Entered $40M bridge facility; borrowed $27.5M to repay all outstanding revolving loans (~$14.3M) and terminate revolver commitments.
Inotiv receives waiver of minimum liquidity covenant for May 2026 test dates
Lenders waived minimum liquidity covenant for May 1 and May 8, 2026 test dates.
Inotiv obtains waiver of minimum liquidity covenant for April 2026 test dates
Lenders under Credit Agreement (Nov 5, 2021) granted waiver of min liquidity covenant for Apr 17 and Apr 24, 2026 test dates.
Inotiv obtains waiver of minimum liquidity covenant for two April 2026 test dates
Lenders waived minimum liquidity covenant for April 3 and April 10, 2026 test dates under Credit Agreement.
Inotiv receives waiver of minimum liquidity covenant for March 20 and 27, 2026 test dates
Lenders waived minimum liquidity covenant for March 20 and March 27, 2026 test dates under the Credit Agreement.
Inotiv obtains lender waiver of minimum liquidity covenant for March 2026 test dates
Lenders waived minimum liquidity covenant for March 6 and March 13, 2026 test dates.
Inotiv Q1 FY2026 revenue up 0.8% to $120.9M; operating loss widens to $16.3M
Revenue $120.9M (+0.8% YoY); DSA segment up 12% to $48M, RMS down 5.4% to $72.9M.
Inotiv receives Nasdaq notice for non-compliance with minimum bid price rule
Received Nasdaq notification on Dec 31, 2025 for failing to maintain minimum $1.00 bid price for 30 consecutive business days.
Inotiv Q4 revenue $138.1M (+5.9% YoY); operating loss down 48.5% to $6.8M
Total revenue $138.1M in Q4 FY2025, up 5.9% YoY; DSA revenue $51.6M (+15.7%), RMS $86.5M (+0.8%).
Inotiv prelim Q4 revenue $137.5-138.5M; full year $512.5-513.5M; DSA awards up 60% YoY
Preliminary Q4 FY2025 revenue $137.5-138.5M, improving over prior year; full year $512.5-513.5M.
Inotiv settles securities class action for $8.75M, derivative settlement with governance changes
$8.75M cash settlement to resolve securities class action; funded by available insurance.
Inotiv reports ransomware attack encrypting systems; business operations disrupted
Threat actor gained unauthorized access and encrypted certain company systems on August 8, 2025.
Inotiv reports Q3 FY2025 revenue up 23.5% to $130.7M; net loss narrows to $17.6M
Quarterly revenue $130.7M (+23.5% YoY); DSA $48.2M (+8.9%), RMS $82.5M (+34.1%).
Inotiv Q3 FY2025 revenue up 23.5% to $130.7M; net loss narrows to $17.6M
Revenue $130.7M, +23.5% YoY; DSA $48.2M (+8.9%), RMS $82.5M (+34.1%).
SEC closes FCPA investigation into Inotiv's primate imports, no enforcement action
On June 2, 2025, SEC Division of Enforcement notified Inotiv it will not recommend enforcement action.
Inotiv settles lagoon design lawsuit with Freese and Nichols for $7.55M
Settlement resolves claims over FNI's failure to design adequate wastewater lagoon at Alice, TX facility.
Inotiv Q1 FY2025 revenue $119.9M (-11.5%); net loss widens to $27.6M
Revenue declined 11.5% to $119.9M; RMS segment down 15.1%, DSA down 4.2%.
Inotiv prices public offering of 6M shares at $4.25; expects ~$24M net proceeds
Priced 6M share offering at $4.25 each; underwriter has 30-day option for up to 900k additional shares.
Inotiv FY2024 revenue down 14.3% to $490.7M; net loss $108.9M; adj. EBITDA falls sharply
Q4 FY2024 revenue $130.4M (-7.3% YoY, +23.3% sequentially); net loss $18.9M vs $8.7M loss YoY.
Inotiv amends credit agreement, issues $22.6M 15% PIK notes, gets covenant relief through June 2025
$22.6M of 15% PIK notes due 2027 issued for $17M cash and $8.3M convertible note cancellation.
Inotiv signs $50M ATM equity facility with Jefferies, 3% commission
$50M of common shares may be sold from time to time via Jefferies as agent in at-the-market offerings.
Inotiv Q3 FY2024 revenue down 32.8% to $105.8M; net loss $26.1M; adjusted EBITDA $0.1M
Revenue fell 32.8% YoY to $105.8M; RMS segment down 44.4% on lower NHP demand and pricing.
Inotiv subsidiaries plead guilty in DOJ canine-facility probe; total payments exceed $35M
Envigo RMS pleaded guilty to misdemeanor conspiracy to violate Animal Welfare Act; EGSI pleaded guilty to felony Clean Water Act conspiracy.
Inotiv Q2 revenue down 21.5%, net loss $48.1M includes $26.5M DOJ charge; withdraws FY2024 guidance
Q2 FY2024 revenue $119.0M (-21.5% YoY); net loss $48.1M vs $9.6M loss prior year.
Inotiv reports Q1 FY2024 revenue up 10.3% to $135.5M; net loss narrows to $15.8M from $86.9M
Adjusted EBITDA turned positive to $9.6M (7.1% of revenue) vs. -$5.5M in prior year.
Inotiv reports FY2023 revenue $572.4M (+4.5%), adj. EBITDA $65.8M; FY2024 guidance $580-590M
Q4 revenue $140.7M (-6.5% YoY) with DSA +13.6% to $50.2M, RMS -14.9% to $90.5M.
Inotiv Q3 revenue $157.5M (-8.8% YoY); cuts FY2023 guidance to at least $570M
Q3 revenue $157.5M, down 8.8% YoY; net income $0.4M vs loss $(3.6M) in Q3 FY2022.
Inotiv Q2 FY2023 revenue $151.5M (+8% YoY); net loss $(9.6)M; cuts FY23 Adj EBITDA guidance to $70M
Revenue $151.5M in Q2 FY2023, up 8% from $140.3M; DSA segment revenue up 20.2%.
Revenue rose 45.8% YoY to $122.8M, driven by acquisitions in DSA (+$8.3M) and RMS (+$30.3M).
Inotiv Q4 FY2022 net loss $243.6M includes $236M goodwill impairment; sees FY2023 rev ≥$580M
Full year revenue $547.7M (up from $89.6M); net loss $(337.3)M vs net income $10.9M prior year.
Second Amendment extends deadline to provide audited FY2022 financials to Jan. 13, 2023 or 10-K filing date.
Inotiv delays FY2022 results; preliminary revenue $547.7M; NHP import probe ongoing
Preliminary FY2022 revenue ~$547.7M (up from $89.6M in FY2021); DSA backlog $147.2M.
Closing two isolator facilities in Indianapolis, IN, consolidating into existing U.S. facilities by end of fiscal year 2023.
Inotiv's primary NHP supplier employees criminally charged with illegal import conspiracy
USAO-SDFL charged employees of Inotiv's main NHP supplier and two Cambodian officials with conspiracy to illegally import NHPs from Dec 2017 to Jan 2022.
the board of managers (the “Board”) of the Reorganized Parent consists of five managers, who were appointed in accordance with the Plan: Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr.
certain officers of the Company, including John E. Sagartz (Chief Strategy Officer) and Adrian P. Hardy (Chief Commercial Officer), resigned as officers of the Company on the Plan Effective Date.
the board of managers (the “Board”) of the Reorganized Parent consists of five managers, who were appointed in accordance with the Plan: Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
the board of managers (the “Board”) of the Reorganized Parent consists of five managers, who were appointed in accordance with the Plan: Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
the board of managers (the “Board”) of the Reorganized Parent consists of five managers, who were appointed in accordance with the Plan: Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr.
certain officers of the Company, including John E. Sagartz (Chief Strategy Officer) and Adrian P. Hardy (Chief Commercial Officer), resigned as officers of the Company on the Plan Effective Date.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
Max materiality 1.00 · Median 0.70 · Most common event other_material